Patents by Inventor Agnes Lo

Agnes Lo has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method of treating renal cancer using carbonic anhydrase IX (G250) antibodies
    Patent number: 11174323
    Abstract: The invention provides scFv antibodies and monoclonal antibodies that bind to and decrease an activity of Carbonic Anhydrase IX (G250). Also provided are the methods of treating and/or preventing cancer, such as renal clear cell cancer. Also provided are methods of identifying a carbonic anhydrase IX (G250) protein. The invention additionally provides methods of modifying immune effector cells, and the immune effector cells modified thereby.
    Type: Grant
    Filed: October 21, 2019
    Date of Patent: November 16, 2021
    Assignee: DANA-FARBER CANCER INSTITUTE, INC.
    Inventors: Wayne A. Marasco, Agnes Lo, Chen Xu, Quan Zhu
  • CARBONIC ANHYDRASE IX (G250) ANTIBODIES AND METHODS OF USE THEREOF
    Publication number: 20200165357
    Abstract: The invention provides scFv antibodies and monoclonal antibodies that bind to and decrease an activity of Carbonic Anhydrase IX (G250). Also provided are the methods of treating and/or preventing cancer, such as renal clear cell cancer. Also provided are methods of identifying a carbonic anhydrase IX (G250) protein. The invention additionally provides methods of modifying immune effector cells, and the immune effector cells modified thereby.
    Type: Application
    Filed: October 21, 2019
    Publication date: May 28, 2020
    Inventors: Wayne A. Marasco, Agnes Lo, Chen Xu, Quan Zhu
  • Carbonic anhydrase IX (G250) antibodies and methods of use thereof
    Patent number: 10450383
    Abstract: The invention provides scFv antibodies and monoclonal antibodies that bind to and decrease an activity of Carbonic Anhydrase IX (G250). Also provided are the methods of treating and/or preventing cancer, such as renal clear cell cancer. Also provided are methods of identifying a carbonic anhydrase IX (G250) protein. The invention additionally provides methods of modifying immune effector cells, and the immune effector cells modified thereby.
    Type: Grant
    Filed: May 9, 2017
    Date of Patent: October 22, 2019
    Assignee: DANA-FARBER CANCER INSTITUTE, INC.
    Inventors: Wayne A. Marasco, Agnes Lo, Chen Xu, Quan Zhu
  • CARBONIC ANHYDRASE IX (G250) ANTIBODIES AND METHODS OF USE THEREOF
    Publication number: 20180072813
    Abstract: The invention provides scFv antibodies and monoclonal antibodies that bind to and decrease an activity of Carbonic Anhydrase IX (G250). Also provided are the methods of treating and/or preventing cancer, such as renal clear cell cancer. Also provided are methods of identifying a carbonic anhydrase IX (G250) protein. The invention additionally provides methods of modifying immune effector cells, and the immune effector cells modified thereby.
    Type: Application
    Filed: May 9, 2017
    Publication date: March 15, 2018
    Inventors: Wayne A. MARASCO, Agnes LO, Chen XU, Quan Zhu
  • Chimeric T cell receptor comprising carbonic anhydrase IX (G250) antibody
    Patent number: 9676867
    Abstract: The invention provides scFv antibodies and monoclonal antibodies that bind to and decrease an activity of Carbonic Anhydrase IX (G250). Also provided are methods of treating and/or preventing cancer, such as renal clear cell cancer. Also provided are methods of identifying a carbonic anhydrase IX (G250) protein. The invention additionally provides methods of modifying immune effector cells, and the immune effector cells modified thereby.
    Type: Grant
    Filed: May 8, 2013
    Date of Patent: June 13, 2017
    Assignee: Dana-Farber Cancer Institute Inc.
    Inventors: Wayne A. Marasco, Agnes Lo, Chen Xu
  • Carbonic Anhydrase IX (G250) Antibodies and Methods of Use Thereof
    Publication number: 20130336923
    Abstract: The invention provides scFv antibodies and monoclonal antibodies that bind to and decrease an activity of Carbonic Anhydrase IX (G250). Also provided are methods of treating and/or preventing cancer, such as renal clear cell cancer. Also provided are methods of identifying a carbonic anhydrase IX (G250) protein. The invention additionally provides methods of modifying immune effector cells, and the immune effector cells modified thereby.
    Type: Application
    Filed: May 8, 2013
    Publication date: December 19, 2013
    Applicant: DANA-FARBER CANCER INSTITUTE, INC.
    Inventors: Wayne A. Marasco, Agnes Lo, Chen Xu
  • Carbonic anhydrase IX (G250) anitbodies
    Patent number: 8466263
    Abstract: The invention provides scFv antibodies and monoclonal antibodies that bind to and decrease an activity of Carbonic Anhydrase IX (G250). Also provided are methods of treating and/or preventing cancer, such as renal clear cell cancer. Also provided are methods of identifying a carbonic anhydrase IX (G250) protein. The invention additionally provides methods of modifying immune effector cells, and the immune effector cells modified thereby.
    Type: Grant
    Filed: December 4, 2006
    Date of Patent: June 18, 2013
    Assignee: Dana-Farber Cancer Institute, Inc.
    Inventors: Wayne A. Marasco, Agnes Lo, Chen Xu
  • CARBONIC ANHYDRASE IX (G250) ANITBODIES AND METHODS OF USE THEREOF
    Publication number: 20090068095
    Abstract: The invention provides scFv antibodies and monoclonal antibodies that bind to and decrease an activity of Carbonic Anhydrase IX (G250). Also provided are methods of treating and/or preventing cancer, such as renal clear cell cancer. Also provided are methods of identifying a carbonic anhydrase IX (G250) protein. The invention additionally provides methods of modifying immune effector cells, and the immune effector cells modified thereby.
    Type: Application
    Filed: December 4, 2006
    Publication date: March 12, 2009
    Inventors: Wayne A. Marasco, Agnes Lo, Chen Xu